Celase GMP

Celase GMP

CelaseBottle
NameQtySizeCatalog Number
Celase GMP135 mg1235-01
NEXT LEVEL RESEARCH

 

 

Celase GMP is a proprietary, blended proteolytic enzyme designed for efficient, gentle and reproducible in vitro dissociation of nucleated cells from adipose tissue.

  • Now available as a standalone product
  • Foundational and versatile for all research programs
  • Eliminates time consuming, costly bridging studies
  • Pack Size: 1 vial, 35 mg
  • Samples: limited quantities available upon request

DISTRIBUTION PARTNERS

LABELING AND SPECIFICATIONS

TISSUE DISSOCIATION PROTOCOLS

PRODUCT COMPARISONS

Celbrush

Celbrush

Celbrush_3mL_syringe
NameQtySizeCatalog Number
Celbrush 3 mL13 mL503/CRS
Celbrush 3 mL Starter Kit13 mL Kit521/CRS
Celbrush 10 mL110 mL510/CRS
Celbrush 10 mL Starter Kit110 mL Kit520/CRS
FOR PRECISION DELIVERY OF MICRO DROPLETS

Celbrush is a stainless steel surgical instrument for precise delivery of micro droplets.  The thumb-brush design gives the Celbrush a mechanical advantage that minimizes the build-up of pressure, and provides superior tactile feedback during tissue dispersion.  This allows the surgeon, with a simple brush of his or her thumb, to exactly control the micro droplet tissue volume injected into the defect area without ever looking at the syringe, while simultaneously avoiding transient syringe obstruction and over-filling of the defect space.

For each full brush of the operator’s thumb, the Celbrush 3 mL and Celbrush 10 mL instruments deliver approximately 0.15 mL and 0.50 mL of tissue, respectively.

LABELING AND SPECIFICATIONS

DISTRIBUTION PARTNERS

Stemsource Cell Bank

Stemsource Cell Bank

StemSource
NameCatalog Number
StemSource 900/MB Tissue Processor900/MB
StemSource Procedure Set920/MB
StemSource Bank Service Plan, 1-Year0962-00
StemSource Bank Service Plan, 3-Year0963-11

The StemSource® Cell Bank is a customized, turn-key, GTP-compliant, turn-key technology designed to provide a high degree of safety and quality in cryopreserving and recovering viable, functioning Adipose Derived Regenerative Cells (ADRCs). The StemSource Cell Bank consists of a Tissue Processor, Procedure Set, Web-Based Processing and Data Management Application, Standard Operating Procedures, and additional equipment such as liquid nitrogen dewar storage tanks, control rate freezers, and biological safety cabinets.

LABELING AND SPECIFICATIONS

EARLY ACCESS PROGRAM SUPPLIES

Early Access Programs provide biopharmaceutical companies with a way to allow compliant and ethical access to their pre-approval medicines to help patients with unmet medical needs. Access is provided in response to physician requests when no alternative treatment options are available. The source of medicine funding varies by country and may be derived from the government, hospital, insurer, and/or patient.

The name ‘Early Access Program’ is analogous to other terms often used for similar programs such as: named patient, special access, expanded access, managed access, early use, compassionate use, single patient IND, treatment IND, special therapeutic, and cohort supply. The names used vary by company, country, program, and regulatory area.

Cytori’s Early Access Program across Europe, Middle East and Latin America (excluding Chile) is intended to provide patients with hand manifestations of systemic scleroderma early access to Habeo Cell Therapy™. These patients typically are unable to participate in ongoing clinical trials due to amongst others lack geographic proximity to a trial site.

Companies such as Cytori which are authorized to distribute unlicensed medicines via an Early Access Program are not involved in the patient-doctor relationship. All information regarding patients is controlled under specific privacy and data protection legislation. Cytori can only distribute where permitted to do so and only in response to an unsolicited information or product supply request.

Cytori’s Early Access Program distributor is myTomorrows:

myTomorrows
Pilotenstraat 45
1059CH Amsterdam
The Netherlands
Tel: +31 88 525 38 88
Website:  http://mytomorrows.com


For product-related questions:
Ozerk Akgun, MD, PhD
Ozerk.akgun@mytomorrows.com
+31 88 525 38 44

Please note: “This contact information is intended for healthcare professionals only.”

Product Gate Open